Skip to main content

Table 1 Measurements in the health examination in the preventive programme, Check your health, including technical information and levels for follow up at the local Health Centre (RHC) or their general practitioner (GP)

From: Effectiveness of the population-based Check your health preventive programme conducted in primary care with 4 years follow-up [the CORE trial]: study protocol for a randomised controlled trial

 

Measurement

Technical information

Levels for referral

Clinical measures

BP (mmHg) - systolic and diastolic

Measured in sitting position at left arm, three times.

To GP:

Average of three measurements

If systolic BP ≥140 or

Device: Omron M6 blood pressure monitor, Omron Healthcare Europe BV

Diastolic BP ≥95

Immediate referral: 200/120

 

Height (cm), weight (kg)

Device: Seca 222 mechanical telescopic measuring rod, Seca, Germany

 
 

BMI (kg/m2)

 

To RHC:

If BMI ≥28 kg/m2

 

Waist (cm)

Device: Seca 203 measuring band, Seca, Deutschland

 

Quality assurance: inter/intra validation, yearly

 

Lung function/spirometry

Device: EasyOne Diagnostic Spirometer, NDD Medical Tecnologies, inc. MA, USA

To GP:

FVC (L,%), FEV1 (L,%), FEV/1FVC

If FEV1 or FVC ≤80% or

Quality assurance: daily calibration, yearly intra/intervariation measurements

FEV1/FVC ≤0.70

 

Physical fitness (ml O2/kg/min)

Aastrand 1 point submaximal test (ref 20)

To RHC:

For men age 30 to 39 yrs: <35

For men age 40 to 49 yrs: <31

Device: Monark 939 E Pendulum Ergometer, Monark Exercise AB, Sweden

For women age 30 to 39 yrs: <28

Quality assurance: daily calibration. Yearly external calibration check. Yearly intra/intervariation measurements

For women age 40 to 49 years: <26

Patient reported by questionnaire

Smoking

Questionnaire: daily, weekly, less than weekly, quitted, never

To RHC:

If current smoker

 

Alcohol use

AUDIT measures risk behaviour. (ref 19)

To GP:

For men if audit score ≥8 or

NAU ≥21 per week

For women if audit score ≥8* or

NAU ≥14 per week

Number of alchohol units (NAU) per week is estimated on basis of reported number per weekday.

*During the first 6 months the referring score was ≥6.

 

Mental Health

SF-12 mcs 2007. Lincoln, RI: QualityMetric Incorporated, 2007.(ref 17)

To GP:

If mental component score <35.76

 

Self-reported general health

Question 1 from SF-12:

To GP:

In general, would you say your health is:

If answer is "Fair" or "Poor"

Excellent, Very good, Good, Fair, Poor

Biochemical

HbA1c

Measured in capillary blood

To GP:

Device: DCA Vantage Analyzer, Siemens Healthcare, Siemens AG, Germany

If HbA1c ≥6,0%/42 mmol/mol

Quality assurance: monthly control test. Every three months: optical calibration test according to manufacturer guidelines.

Immediate referral: HbA1c ≥8,0%/63 mmol/mol

 

Lipid profile (total cholesterol, HDL, LDL, triglyceride)

Measured in capillary blood

To GP:

Device: Alere Cholestech LDX System, Alere Denmark

If total cholesterol > =6 mmol/l or

Quality assurance: Daily calibration. Yearly calibration check according to manufacturer guidelines

LDL ≥6 mmol/l

Aggregated measure

Risk of CVD within 10 years

Measured by SCORE (ref 21), includes information on systolic blood pressure, Total cholesterol, smoking, gender and age. Denmark is categorized as a low-risk country.

To GP:

If score ≥5%

  1. BP, blood pressure; BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume at one second; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CVD, cardiovascular disease; AUDIT, alcohol use disorders identification test; WHO, World Health Organisation; NAU, number of alcohol units; SF12 mcs, Short form 12 mental component score.